Does TREMELIMUMAB Cause Biliary tract infection? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Biliary tract infection have been filed in association with TREMELIMUMAB (IMJUDO). This represents 2.4% of all adverse event reports for TREMELIMUMAB.
58
Reports of Biliary tract infection with TREMELIMUMAB
2.4%
of all TREMELIMUMAB reports
0
Deaths
58
Hospitalizations
How Dangerous Is Biliary tract infection From TREMELIMUMAB?
Of the 58 reports, 58 (100.0%) required hospitalization.
Is Biliary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB Cause?
Pyrexia (178)
Diarrhoea (136)
Death (116)
Colitis (115)
Pneumonitis (87)
Pneumonia (85)
Sepsis (82)
Vomiting (78)
Febrile neutropenia (72)
Malignant neoplasm progression (68)
What Other Drugs Cause Biliary tract infection?
PACLITAXEL (105)
GEMCITABINE (92)
DURVALUMAB (72)
OXALIPLATIN (39)
FLUOROURACIL (32)
NIVOLUMAB (29)
LEUCOVORIN (24)
IRINOTECAN (23)
ATEZOLIZUMAB (22)
BEVACIZUMAB (19)
Which TREMELIMUMAB Alternatives Have Lower Biliary tract infection Risk?
TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TREMELIMUMAB vs TRENBOLONE
TREMELIMUMAB vs TREOSULFAN
TREMELIMUMAB vs TREPROSTINIL
TREMELIMUMAB vs TREPROSTINIL DIOLAMINE